Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03700047 · ClinicalTrials.gov registry record · NA
GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT03700047 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 270 participants.
The verdict
NCT03700047, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.
Interventions
- DEVICE Juvederm Voluma
- DEVICE GAL1704
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2020-05-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03700047
The ClinicalTrials.gov registry entry for NCT03700047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Juvederm Voluma is the first listed.
NCT03700047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03700047 about?
NCT03700047 is a clinical study titled "GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies". An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.
What is the current status of trial NCT03700047?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2018-10-18. Estimated completion is 2020-05-22.
What interventions are being tested in trial NCT03700047?
The interventions under investigation include: Juvederm Voluma (DEVICE), GAL1704 (DEVICE).
Who is sponsoring clinical trial NCT03700047?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.